TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18628419

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg alone
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: CEE + daily medroxyprogesterone acetate (MPA) 2.5 mg
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: CEE + cyclical MPA (10 mg days 1‐12 per 28‐day cycle)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: CEE + cyclical micronized progesterone (10 mg days 1‐12)
Number of subjects: 428
Study: 16266650

Group type: EXPERIMENTAL
Intervention: Educational intervention (four 45-minute training sessions over 2 months)
Number of subjects: 376

Group type: COMPARATOR
Intervention: Control group (only received feedback and bulletins)
Number of subjects: 376
Study: 12244891

Group type: EXPERIMENTAL
Intervention: 240 mg/die Egb 761 (group I = 50 patients)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: 60 mg/die Egb 761 (group II = 49 patients)
Number of subjects: 99
Study: 10071708

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 526

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 526
Study: 7741412

Group type: EXPERIMENTAL
Intervention: Pacemaker implantation (PMG)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 450
Study: 1828266

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 394275

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltarol)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both treatments (Diclofenac and Indomethacin)
Number of subjects: 109
Study: 31625535

Group type: EXPERIMENTAL
Intervention: Work Engagement (WE)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hiding Feelings (HF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Work Engagement (WE) with Hiding Feelings (HF)
Number of subjects: 100
Study: 26559707

Group type: EXPERIMENTAL
Intervention: Nut-based snack bars (NBSB)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional snack foods
Number of subjects: 34
Study: 26359580

Group type: EXPERIMENTAL
Intervention: Continuous scanning technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sequential scanning technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phantom evaluation
Number of subjects: 0
Study: 22451113

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1527

Group type: EXPERIMENTAL
Intervention: Accelerometer data
Number of subjects: 1527
Study: 23115402

Group type: EXPERIMENTAL
Intervention: Phentermine 15 mg plus extended-release topiramate 92 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 20216464

Group type: EXPERIMENTAL
Intervention: L-carnitine (20 mg kg(‐1) i.v.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17977294

Group type: EXPERIMENTAL
Intervention: Zinc lactate (n = 16)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Amine fluoride-stannous fluoride (n = 13)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Triclosan (n = 15)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No antimicrobial agent (control; n = 15)
Number of subjects: 59
Study: 15743361

Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg IV bolus, n = 22)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: High dose of somatostatin (500 microg/h, n = 20)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (n = 7)
Number of subjects: 80
Study: 11666118

Group type: EXPERIMENTAL
Intervention: Total triterpenic fraction of Centella asiatica (TTFCA), 60 mg, oral tablets, thrice daily for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total triterpenic fraction of Centella asiatica (TTFCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 9638783

Group type: EXPERIMENTAL
Intervention: Adjuvant Psychological Therapy (APT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 57
Study: 8037558

Group type: EXPERIMENTAL
Intervention: Intermittent antegrade warm blood cardioplegia
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cold blood cardioplegia
Number of subjects: 200
Study: 3290413

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 mg/kg/dose twice daily for 2 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (for 2 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 70
Study: 29635503

Group type: EXPERIMENTAL
Intervention: Smaller portion size of food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Larger portion size of food
Number of subjects: 0
Study: 27871643

Group type: EXPERIMENTAL
Intervention: Reward positivity (RewP) response in children with depression
Number of subjects: 78

Group type: COMPARATOR
Intervention: Reward positivity (RewP) response in healthy children
Number of subjects: 78
Study: 24605812

Group type: EXPERIMENTAL
Intervention: ATX-101 1 mg/cm²
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: ATX-101 2 mg/cm²
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 22995944

Group type: EXPERIMENTAL
Intervention: C-QIDS-C
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: C-QIDS-SR
Number of subjects: 998

Group type: COMPARATOR
Intervention: HAMD
Number of subjects: 998
Study: 20718225

Group type: EXPERIMENTAL
Intervention: Speeded condition for Session 1
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Complying with the 95% reliable diagnostic aid
Number of subjects: 72
Study: 19080399

Group type: EXPERIMENTAL
Intervention: 30 mg/d of prednisone for 7 days
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: 30 mg/d of prednisone for 10 days, then tapered to 15 mg/d for 4 days
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo for 14 days
Number of subjects: 130
Study: 15974845

Group type: EXPERIMENTAL
Intervention: Locally delivered doxycycline hyclate (DHV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control (VC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 12867675

Group type: EXPERIMENTAL
Intervention: Video intervention group
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Telephone intervention group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 27
Study: 10553827

Group type: EXPERIMENTAL
Intervention: 0.5 mg midazolam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 2 mg midazolam
Number of subjects: 90

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 90
Study: 8688991

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1854868

Group type: EXPERIMENTAL
Intervention: UV light sterilization with the UV‐XD bag transfer set
Number of subjects: 51

Group type: COMPARATOR
Intervention: Bag transfer set without UV light
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both techniques (UV light and non-UV light)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: UV light sterilization
Number of subjects: 51
Study: 6853286

Group type: EXPERIMENTAL
Intervention: CVE (central vascular engorgement) via G-suit inflation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Immersion in water
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study: 30003332

Group type: EXPERIMENTAL
Intervention: Glycomacropeptide (GMP) 50g
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Whey protein isolate (WPI) 50g
Number of subjects: 15

Group type: COMPARATOR
Intervention: Maltodextrin 19 (MD19)
Number of subjects: 15
Study: 30193277

Group type: EXPERIMENTAL
Intervention: CJR bundled payment model
Number of subjects: 130343

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 130343
Study: 26817718

Group type: EXPERIMENTAL
Intervention: Plasma 25(OH)D concentration quartile 4 (Q4) compared with quartile 1 (Q1) for women with BMI < 22.4
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Plasma 25(OH)D concentration quartile 4 (Q4) compared with quartile 1 (Q1) for women with BMI ≥ 22.4
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Plasma 25(OH)D concentration ≥ 10 ng/mL compared with <10 ng/mL for women with alcohol intake ≥ 7.1 g/d
Number of subjects: 699
Study: 25183726

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg
Number of subjects: 378

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 378
Study: 22037407

Group type: EXPERIMENTAL
Intervention: quetiapine (400 mg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: matched placebo
Number of subjects: 20
Study: 20670575

Group type: EXPERIMENTAL
Intervention: 3D computer-assisted navigation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional fluoroscopic control
Number of subjects: 42
Study: 17765968

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: EMG
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study: 15132959

Group type: EXPERIMENTAL
Intervention: Stenting at the choke point
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Secondary stenting at migrated choke points
Number of subjects: 64
Study: 11087205

Group type: EXPERIMENTAL
Intervention: Meningococcal A/C conjugate vaccination (MenA/C)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Meningococcal A/C polysaccharide (MPS)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Inactivated polio vaccine (IPV)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (unvaccinated age-matched subjects)
Number of subjects: 39
Study: 10358462

Group type: EXPERIMENTAL
Intervention: Octreotide (200 micrograms s.c. every 8 hours)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (standard conservative treatment without octreotide)
Number of subjects: 21
Study: 7641928

Group type: EXPERIMENTAL
Intervention: Direct verbal instruction
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual written instructions
Number of subjects: 104
Study: 2663610

Group type: EXPERIMENTAL
Intervention: Clonidine (0.9 mg/24 h orally for 72 h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 766572

Group type: EXPERIMENTAL
Intervention: Lidoflazine (60 mg tablet t.i.d.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30459959

Group type: EXPERIMENTAL
Intervention: Group antenatal care
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 72
Study: 27723631

Group type: EXPERIMENTAL
Intervention: 10% Anacardium occidentale (AO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine digluconate (CLX)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (PB)
Number of subjects: 30
Study: 25073797

Group type: EXPERIMENTAL
Intervention: ABC program delivered at a daycare centre only
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ABC program delivered at daycare with a home/parental education component
Number of subjects: 18

Group type: COMPARATOR
Intervention: Regular daycare curriculum
Number of subjects: 18
Study: 22981021

Group type: EXPERIMENTAL
Intervention: Primary Care (PC)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Community Mental Health (CMH)
Number of subjects: 384
Study: 20530316

Group type: EXPERIMENTAL
Intervention: Accelerated-fractionation radiotherapy combined with cisplatin therapy
Number of subjects: 323

Group type: COMPARATOR
Intervention: Standard-fractionation radiotherapy combined with cisplatin therapy
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: HPV-positive tumors
Number of subjects: 323

Group type: COMPARATOR
Intervention: HPV-negative tumors
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Tobacco exposure
Number of subjects: 323
Study: 18400703

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet
Number of subjects: 8
Study: 15196517

Group type: EXPERIMENTAL
Intervention: Gait characteristics measured in transitionally frail older adults
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison with published results from other older adults
Number of subjects: 50
Study: 11751664

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Substance P (2‐8 pmol/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (1‐4 microg/min)
Number of subjects: 16
Study: 9717790

Group type: EXPERIMENTAL
Intervention: measuring‐mounting catheter
Number of subjects: 10

Group type: COMPARATOR
Intervention: visual assessment
Number of subjects: 10
Study: 7714681

Group type: EXPERIMENTAL
Intervention: Regimen ADJ (new fortification regimen with bovine milk proteins)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Regimen ADJ
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regimen FIX (conventional fixed proportion with bovine milk proteins)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Regimen FIX
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Regimen HMP (human milk protein-based fortifier)
Number of subjects: 12
Study: 2668407

Group type: EXPERIMENTAL
Intervention: Atenolol (mean dose 67 mg/day)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Diltiazem (mean dose 329 mg/day)
Number of subjects: 58
Study: 785950

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31006671

Group type: EXPERIMENTAL
Intervention: Observation group (patients with type 2 diabetes mellitus)
Number of subjects: 80
Study: 29111130

Group type: EXPERIMENTAL
Intervention: Transbond XT after etching with 37% phosphoric acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC after etching with 37% phosphoric acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC after deproteinization with 5.25% NaOCl and etching with 37% phosphoric acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC after sandblasting with 50μm aluminium oxide and etching with 37% phosphoric acid
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC after both sandblasting with 50μm aluminium oxide and deproteinization with 5.25% NaOCl, followed by etching with 37% phosphoric acid
Number of subjects: 150
Study: 25963642

Group type: EXPERIMENTAL
Intervention: Transcultural prevention approach (prevention event + cultural and language-sensitive information booklet)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Transcultural prevention approach
Number of subjects: 310

Group type: COMPARATOR
Intervention: Control condition (general prevention event with materials from Deutsche Hauptstelle für Suchtfragen)
Number of subjects: 310
Study: 23864054

Group type: EXPERIMENTAL
Intervention: benidipine-ARB
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: benidipine-BB
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: benidipine-TD
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 834
Study: 21677895

Group type: EXPERIMENTAL
Intervention: SensAwake ON
Number of subjects: 42

Group type: COMPARATOR
Intervention: SensAwake OFF
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: AutoCPAP AHI
Number of subjects: 42
Study: 19672264

Group type: EXPERIMENTAL
Intervention: Gemcitabine (G) 1000 mg m(‐2) on D1, 8, 15 q28d (Arm A)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Cisplatin (C) 25 mg m(‐2) followed by Gemcitabine (G) 1000 mg m(‐2) D1, 8 q21d (Arm B)
Number of subjects: 86
Study: 16413247

Group type: EXPERIMENTAL
Intervention: Cranberry juice (8 oz)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Cranberry juice placebo (8 oz)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Brewed tea (8 oz)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Grape juice (8 oz)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fluconazole (8 oz)
Number of subjects: 14
Study: 15322323

Group type: EXPERIMENTAL
Intervention: 50 mg sildenafil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sildenafil vs. Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 20
Study: 11372549

Group type: EXPERIMENTAL
Intervention: unoprostone isopropyl 0.15%
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 9240593

Group type: EXPERIMENTAL
Intervention: Ultralow dose of parenteral estradiol (7.5 microg/24 hours) delivered by vaginal rings
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 30
Study: 8204230

Group type: EXPERIMENTAL
Intervention: GA/PM (general anesthesia-parenteral morphine as needed)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EA/PM (epidural anesthesia-parenteral morphine as needed)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EA/EM (epidural anesthesia-epidural morphine 4 to 5 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: EA/EM
Number of subjects: 36
Study: 3499730

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31749018

Group type: COMPARATOR
Intervention: Active Control Intervention (ACI), educational lessons
Number of subjects: 128

Group type: COMPARATOR
Intervention: Partial Intervention (PI), homotaurine administration (100 mg/die) and lessons on the Mediterranean diet
Number of subjects: 128

Group type: COMPARATOR
Intervention: Multilevel Intervention (MI), PI plus computerized cognitive training and physical exercise training
Number of subjects: 128
Study: 28495209

Group type: EXPERIMENTAL
Intervention: Rule initiated by one child
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Rule initiated collaboratively
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Rule initiated by an adult authority figure
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Child's own solitary rule
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Moral and conventional rules in daily life
Number of subjects: 3
Study: 26660396

Group type: EXPERIMENTAL
Intervention: Fones technique training
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Modified Bass technique training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Basic instructions of oral hygiene (control group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 70
Study: 24393153

Group type: EXPERIMENTAL
Intervention: Topical regular crystalline insulin (containing zinc)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aqueous zinc chloride solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acute wounds
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patients ≤40 years
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Upper body wounds
Number of subjects: 90
Study: 22836067

Group type: EXPERIMENTAL
Intervention: Niacin therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: AIM-HIGH trial
Number of subjects: 0
Study: 19561649

Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (BDP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 18174038

Group type: EXPERIMENTAL
Intervention: Very-low-carbohydrate, high-fat (VLCHF) diet
Number of subjects: 88

Group type: COMPARATOR
Intervention: High-carbohydrate, low-fat (HCLF) diet
Number of subjects: 88
Study: 14982679

Group type: EXPERIMENTAL
Intervention: Separation Anxiety Test (SAT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Responses to pictures of children about to experience pain in the presence of parent figures
Number of subjects: 60
Study: 11275884

Group type: EXPERIMENTAL
Intervention: Follow-up at 24 months (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Follow-up at 48 months (Group B)
Number of subjects: 42
Study: 9397127

Group type: EXPERIMENTAL
Intervention: Stress-point nursing intervention for parents
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 50
Study: 8200210

Group type: EXPERIMENTAL
Intervention: One Touch II blood glucose meter
Number of subjects: 267
Study: 3610513

Group type: EXPERIMENTAL
Intervention: Benzydamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31803482

Group type: EXPERIMENTAL
Intervention: GLP1RA+BI (detemir plus liraglutide)
Number of subjects: 120

Group type: COMPARATOR
Intervention: BBI (detemir plus aspart)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: GLP1RA+BI
Number of subjects: 120

Group type: COMPARATOR
Intervention: BBI
Number of subjects: 120
Study: 29401239

Group type: EXPERIMENTAL
Intervention: Targeted therapy of underlying conditions (including mineralocorticoid receptor antagonists, statins, ACE inhibitors/ARBs, and cardiac rehabilitation)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 245
Study: 26670823

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT) for insomnia, delivered in a five-session format.
Number of subjects: 239

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) for insomnia delivered by mental health practitioners.
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Group CBT for insomnia at 20 weeks follow-up.
Number of subjects: 239

Group type: COMPARATOR
Intervention: TAU for insomnia at 20 weeks follow-up.
Number of subjects: 239
Study: 24447519

Group type: EXPERIMENTAL
Intervention: Biomarker-led care (prednisone, tacrolimus, mycophenolate mofetil)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (current therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biomarker-led care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study: 23049836

Group type: EXPERIMENTAL
Intervention: Monthly installment schedule
Number of subjects: 200
Study: 20943938

Group type: EXPERIMENTAL
Intervention: Disasters spreading from a different state (earthquake, environmental risk)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Disasters spreading from the same state
Number of subjects: 3